| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $839.0M | -17.6% |
| Cost of Revenue | $462.2M | -17.9% |
| Gross Profit | $376.8M | -17.1% |
| R&D Expense | $109.0M | +3.3% |
| SG&A Expense | $83.2M | +18.3% |
| Operating Income | $119.3M | -43.4% |
| Pre-tax Income | $138.2M | -40.0% |
| Income Tax | $18.0M | -38.5% |
| Net Income | $120.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $145.5M | +17.8% |
| Short-term Investments | $228.8M | -48.9% |
| Accounts Receivable | $168.5M | -17.1% |
| Inventory | $329.0M | +16.6% |
| Current Assets | $943.2M | -16.1% |
| Total Assets | $1.36B | +0.9% |
| Current Liabilities | $197.7M | -4.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $118.3M | -16.0% |
| Capital Expenditures | $11.3M | -7.3% |
| Investing Cash Flow | $29.9M | +127.5% |
| Financing Cash Flow | -$124.5M | -74.9% |
| Free Cash Flow | $107.0M | -16.8% |
| -40.2% |
| EPS (Basic) | $3.81 | -38.2% |
| EPS (Diluted) | $3.80 | -38.2% |
| Total Liabilities |
| $326.7M |
| -2.8% |
| Stockholders' Equity | $1.03B | +2.2% |